article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most importantly the high failure rate. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.

article thumbnail

Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses?

Healthcare ECONOMIST

Cost effectiveness analyses (CEA) aim to examine how a new health technologies impact health outcomes and costs over a patient’s lifetime. This is particularly relevant for pharmaceuticals. The need for dynamic pricing is particularly important when comparing pharmaceutical to non-pharmaceutical health technologies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good 

Bill Of Health

The Pandemic Treaty (or other legal instrument) scheduled for discussion at the World Health Assembly in the fall of 2021 should focus on establishing the norm that the IP and knowledge needed to develop and produce essential pandemic health technologies become global public goods. and German governments in particular.

article thumbnail

Bone Health Technologies Acquires Wellen to Deliver Personalized, Non-Drug Osteoporosis Care

HIT Consultant

A Comprehensive Solution Anchored by Innovation This acquisition positions BHT to achieve its vision of a holistic bone health solution. The Wellen program will bring tremendous value to our platform,” said Laura Yecies , CEO of Bone Health Technologies.

article thumbnail

Verily Powers Otsuka’s Longitudinal Registry to Advance Mental Health Research

HIT Consultant

What You Should Know: – Otsuka Pharmaceutical Development & Commercialization, Inc. Otsuka) , a global pharmaceutical company, and Verily Life Sciences LLC (Verily) , a precision health technology company, have teamed up to launch a groundbreaking research initiative called “ My Mental Health Journey.”

article thumbnail

Philips Appoints Charlotte Hanneman as New CFO, Succeeding Abhijit Bhattacharya

HIT Consultant

Charlotte-Hanneman, CFO at Philips What You Should Know: – Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the appointment of Charlotte Hanneman as its new Chief Financial Officer (CFO). Hanneman brings over 20 years of experience in the MedTech and pharmaceutical industries. – Ms.

article thumbnail

CareYaya Unveils AI-Powered Smart Glasses to Assist Dementia Patients

HIT Consultant

What You Should Know: – CareYaya Health Technologies , a leading innovator in AI-powered solutions for the aging population, has launched MedaCareLLM, a new AI platform designed to assist individuals with dementia and Alzheimer’s disease. Shah , CEO and co-founder of CareYaya Health Technologies.